Robert Nelsen

Robert Nelsen General Information

Biography

Mr. Robert Nelsen is a Co-Founder and serves as Managing Director at ARCH Venture Partners. Mr. Nelsen serves as Board Member at Xaira Therapeutics and City Therapeutics. He serves as Board Member at Paradigm (Healthcare Technology Systems). He serves as a Board Member at Aera Therapeutics. He served as a Board Member at Feelmore Labs. He is the Founder & serves as Director at Rsquared. He is a Co-Founder and serves as Chairman at Rippl Care He is a Co-Founder and serves as Board Member at Neumora. He is the Founding Partner at R2 Risk & Return. He was a Board Member at Arivale. He also serves as the Investment Advisory Board at AIF. He serves as a Board Member at GRAIL, Prime Medicine, and Wisdo. He is a Co-Founder and serves as Chairman at Resilience. He is a Co-Founder and Board Member of Vir Biotechnology and Brii Biosciences. He serves as a Board Member at SciNeuro Pharmaceuticals, Nutcracker, Therapeutics, insitro, Encoded Therapeutics, Beam Therapeutics,Seaport Therapeutics, and Lyell. He is a Director of Sana Biotechnology. He is also a Board Member of Agios Pharmaceuticals since December 2007. Additionally, he also served as an Advisor at Mighty AI. He is a Co-Founder of ARCH Venture Partners, a venture capital firm, and has served in various capacities for ARCH and affiliated entities since 1986. He also served as a board member at Revolution Healthcare Acquisition. He is currently a Managing Director of ARCH Venture Corporation. He has played a significant role in the early sourcing, financing, and development of more than 30 companies. He served as a Board Member at Ensemble Therapeutics. He is a Director of Sapphire Energy, Inc., Ensemble Therapeutics Corporation, Juno Therapeutics, Inc., Syros Pharmaceuticals Inc., Denali Therapeutics, and Faraday Pharmaceuticals, Inc. among other companies. He previously served on the boards of Bellerophon Therapeutics, Inc., Fate Therapeutics, Inc., Elixir Pharmaceuticals, Inc., Ikaria Inc., Kythera Biopharmaceuticals, Inc., NeurogesX, Inc., Sage Therapeutics, Inc. and entities affiliated with deCode Genetics, Inc., among others. He was previously a Trustee of the Fred Hutchinson Cancer Research Institute, the Institute for Systems Biology, and a director of the National Venture Capital Association. He received a B.S. with majors in biology and economics from the University of Puget Sound and an M.B.A. from the University of Chicago. He serves as an Advisor at CityBldr. He served as a Board Member at Xtremity. He serves as a Senior Advisor at Red Cell Partners. He serves as a Board Member at Synchron. He served as a Board Member at Gossamer Bio.